Institutional investors have boosted positions in UHC stock, signaling confidence in 2024 earnings guidance; this aligns with upward adjustments seen in the consensus stock forecast. An increase like that would mean tighter margins and less overhead for a company that already slashed its forecast earlier this year . That news sent its stock price down by 22%, its biggest drop in a single day since 1998 . Despite a turbulent start to the year, the healthcare services giant’s recent leadership changes and insider investments signal a potential path to recovery. And investors would be wise to pay attention: when executives are buying big, it often signals the bottom is in . On the earnings front, the latest UHC stock forecast expects quarterly EPS to beat consensus by 2–3%, supported by disciplined cost management.